PSYENCE BIOMEDICAL LTD. - PBM

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q3 2024 · Q2 2024
Value (USD)
Total reported value ($000)
$62K
QoQ value delta ($000)
-$54K (-46.55%)
Implied price effect (QoQ)
-68.41%
Shares
Total shares
660,532
QoQ shares delta
+270,157 (+69.2%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (PBM)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q3 2024)

Top 25 only Full list
Early Q2 2026 data: only 9 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
CANTOR FITZGERALD, L. P. 33 337,000 0.0%
CITADEL ADVISORS LLC 16 169,251 0.0%
MORGAN STANLEY 4 48,407 0.0%
JANE STREET GROUP, LLC 4 45,963 0.0%
Tower Research Capital LLC (TRC) 3 34,391 0.0%
GEODE CAPITAL MANAGEMENT, LLC 1 10,488 0.0%
UBS Group AG 1 15,030 0.0%
JPMORGAN CHASE & CO 0 2 0.0%